Regular updates related to sourcing and the management of health products are available on this page.
-
21 November 2023
Update to Evaluation of Diagnostic Products – African-Manufactured HIV Rapid Tests
The open Expert Review Panel for Diagnostic Products (ERPD) call for Expression of Interest (EOI) for HIV rapid diagnostic tests manufactured in Africa (GF/ERPD/Adhoc 24/08-2023) has been updated to expand the eligibility to include tests manufacture... -
22 May 2023
Opportunity for Evaluation of Diagnostic Products - Malaria Rapid Diagnostic Tests
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). -
19 October 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). -
18 July 2022
Placing Orders and Procuring Health Products for 2023
-
13 June 2022
Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics. -
20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India